Naphthyldesferrithiocin Iron Chelators
J ournal of Medicinal Chemistry, 1996, Vol. 39, No. 8 1581
(13) Bickel, H.; Hall, G. E.; Keller-Schierlein, W.; Prelog, V.; Vischer,
E.; Wettstein, A. Metabolic Products of Actinomycetes. XXVII.
Constitutional Formula of Ferrioxamine B. Helv. Chim. Acta
1960, 43, 2129-2138.
(14) Aksoy, M.; Seyithanoglu, B. Y.; Bozbora, A. Thalassemia and
Desferrioxamine (Desferal) - Introductory Remarks, and Clinical
Laboratory Observations. In Hypertension and Iron Chelation
in Thalassemia; Aksoy, M., Birdwood, G. F. B., Eds.; Berne:
Huber, 1984; p 11.
(15) Graziano, J . H.; Markenson, A.; Miller, D. R.; Chang, H.; Bestak,
M.; Meyers, P.; Pisciotto, P.; Rifkind, A. Chelation Therapy in
â-Thalassemia Major. I. Intravenous and Subcutaneous Defer-
oxamine. J . Pediatr. 1978, 92, 648-652.
(16) Pippard, M. J .; Callender, S. T. The Management of Iron
Chelation Therapy. Br. J . Haematol. 1983, 54, 503-507.
(17) Propper, R. D.; Cooper, B.; Rufo, R. R.; Nienhuis, A. W.;
Anderson, W. F.; Bunn, H. F.; Rosenthal, A.; Nathan, D. G.
Continuous Subcutaneous Administration of Deferoxamine in
Patients with Iron Overload. N. Engl. J . Med. 1977, 297, 418-
423.
(18) Peter, H. H.; Industrial Aspects of Iron Chelators: Pharmaceuti-
cal Applications. In Proteins Iron Storage Transp., Proc. Inter.
Conf. Proteins Iron Metab., 7th; Spik, G., Ed.; Elsevier: Am-
sterdam, The Netherlands, 1985; p 293.
(19) Anderegg, G.; L’Eplattenier, F.; Schwarzenbach, G. Hydroxamate
Complexes. III. Iron (III) Exchange between Sideramines and
Complexones. A Discussion of the Formation Constants of the
Hydroxamate Complexes. Helv. Chim. Acta 1963, 46, 1409-
1422.
(20) Bergeron, R. J .; Streiff, R. R.; Wiegand, J .; Vinson, J . R. T.;
Luchetta, G.; Evans, K. M.; Peter, H.; J enny, H.-B. A Compara-
tive Evaluation of Iron Clearance Models. Ann. N. Y. Acad. Sci.
1990, 612, 378-393.
(21) Kirking, M. H. Treatment of Chronic Iron Overload. Clin.
Pharmacol. 1991, 10, 775-783.
(22) Ponka, P.; Borova, J .; Neuwirt, J .; Fuchs, O. Mobilization of Iron
from Reticulocytes. Identification of Pyridoxal Isonicotinoyl
Hydrazone as a New Iron Chelating Agent. FEBS Lett. 1979,
97, 317-321.
(23) Uhlir, L. C.; Durbin, P. W.; J eung, N.; Raymond, K. N. Specific
Sequestering Agents for the Actinides. 21. Synthesis and Initial
Biological Testing of Octadentate Mixed Catecholate-Hydroxy-
pyridinonate Ligands. J . Med. Chem. 1993, 36, 504-509.
(24) Kontoghiorghes, G. J .; Aldouri, M. A.; Sheppard, L.; Hoffbrand,
A. V. 1,2-Dimethyl-3-hydroxypyrid-4-one, an Orally Active Ch-
elator for Treatment of Iron Overload. Lancet 1987, 1, 1294-
1295.
(25) Grady, R. W.; Hershko, C. HBED: A Potential Oral Iron
Chelator. Ann. N. Y. Acad. Sci. 1990, 612, 361-368.
(26) Guterman, S. K.; Morris, P. M.; Tannenberg, W. J . K. Feasibility
of Enterochelin as an Iron-Chelating Drug: Studies with Human
Serum and a Mouse Model System. Gen. Pharmacol. 1978, 9,
123-127.
(27) Grady, R. W.; Peterson, C. M.; J ones, R. L.; Graziano, J . H.;
Bhargava, K. K.; Berdoukas, V. A.; Kokkini, G.; Loukopoulos,
D.; Cerami, A. Rhodotorulic Acid-Investigation of its Potential
as an Iron-Chelating Drug. J . Pharmacol. Exp. Ther. 1979, 209,
342-348.
(28) Bergeron, R. J . Synthesis and Solution Structure of Microbial
Siderophores. Chem. Rev. 1984, 84, 587-602.
(29) Bergeron, R. J .; McManis, J . S. Synthesis of Catecholamide and
Hydroxamate Siderophores. In Handbook of Microbial Iron
Chelates; Winkelmann, G., Ed.; CRC Press: Boca Raton, FL,
1991; pp 271-307.
(30) Cox, C. D.; Rinehart, K. L., J r.; Moore, M. L.; Cook, J . C., J r.
Pyochelin: Novel Structure of an Iron-Chelating Growth Pro-
moter for Pseudomonas aeruginosa. Proc. Natl. Acad. Sci. U.S.A.
1981, 78, 4256-4260.
(31) Smith, M. J . Total Synthesis and Absolute Configuration of
Rhizobactin, a Structurally Novel Siderophore. Tetrahedron Lett.
1989, 30, 313-316.
(32) Naegeli, H.-U.; Zaehner, H. Metabolites of Microorganisms. Part
193. Ferrithiocin. Helv. Chim. Acta 1980, 63, 1400-1406.
(33) Anderegg, G.; Raeber, M. Metal Complex Formation of a New
Siderophore Desferrithiocin and of Three Related Ligands. J .
Chem. Soc., Chem. Commun. 1990, 1194-1196.
(34) Longueville, A.; Crichton, R. R. An Animal Model of Iron
Overload and its Application to Study Hepatic Ferritin Iron
Mobilization by Chelators. Biochem. Pharmacol. 1986, 35, 3669-
3678.
(35) Wolfe, L. C.; Nicolosi, R. J .; Renaud, M. M.; Finger, J .; Hegsted,
M.; Peter, H.; Nathan, D. G. A Non-Human Primate Model for
the Study of Oral Iron Chelators. Br. J . Haematol. 1989, 72,
456-461.
(36) Bergeron, R. J .; Wiegand, J .; Dionis, J . B.; Egli-Karmakka, M.;
Frei, J .; Huxley-Tencer, A.; Peter, H. H. Evaluation of Desfer-
rithiocin and its Synthetic Analogues as Orally Effective Iron
Chelators. J . Med. Chem. 1991, 34, 2072-2078.
(37) Bergeron, R. J .; Streiff, R. R.; Creary, E. A.; Daniels, R. D., J r.;
King, W.; Luchetta, G.; Wiegand, J .; Moerker, T.; Peter, H. H.
A Comparative Study of the Iron-Clearing Properties of Desfer-
rithiocin Analogues with Desferrioxamine B in a Cebus Monkey
Model. Blood 1993, 81, 2166-2173.
(38) Bergeron, R. J .; Streiff, R. R.; Wiegand, J .; Luchetta, G.; Creary,
E. A.; Peter, H. H. A Comparison of the Iron-Clearing Properties
of 1,2-Dimethyl-3-hydroxypyrid-4-one, 1,2-Diethyl-3-hydroxypy-
rid-4-one and Deferoxamine. Blood 1992, 79, 1882-1890.
(39) Hahn, F. E.; McMurry, T. J .; Hugi, A.; Raymond, K. N.
Coordination Chemistry of Microbial Iron Transport. 42. Struc-
tural and Spectroscopic Characterization of Diastereomeric Cr-
(III) and Co(III) Complexes of Desferrithiocin. J . Am. Chem. Soc.
1990, 112, 1854-1860.
(40) Bergeron, R. J .; Liu, C. Z.; McManis, J . S.; Xia, M. X. B.; Algee,
S. E.; Wiegand, J . The Desferrithiocin Pharmacophore. J . Med.
Chem. 1994, 37, 1411-1417.
(41) Brain, E. G.; Doyle, F. P.; Mehta, M. D.; Miller, D.; Nayler, J .
H. C.; Stove, E. R. Derivatives of 6-Aminopenicillanic Acid. Part
IV. Analogues of 2,6-Dimethoxyphenylpenicillin in the Naph-
thalene and Quinoline Series. J . Chem. Soc. 1963, 491-497.
(42) Lindgren, B. O.; Nilsson, T. Preparation of Carboxylic Acids from
Aldehydes (Including Hydroxylated Benzaldehydes) by Oxida-
tion with Chlorite. Acta Chem. Scand. 1973, 27, 888-890.
(43) Bergeron, R. J .; McManis, J . S.; Dionis, J . B.; Garlich, J . R. An
Efficient Total Synthesis of Agrobactin and Its Gallium(III)
Chelate. J . Org. Chem. 1985, 50, 2780-2782.
(44) J ob, P. Formation and Stability of Inorganic Complexes in
Solution. Ann. Chim. (Paris) 1928, 9, 113-203.
(45) Bukata, S.; Marinsky, J . A. J ob’s Method of Continuous Varia-
tions with Ion Exchange for the Study of Complexes in Solution.
J . Phys. Chem. 1964, 68, 258-260.
(46) Lesser, R.; Kranepuhl, E.; Gad, G. The Constitution of Naph-
thalenes and their Derivatives. Chem. Ber. 1925, 58, 2109-2124.
J M9508752